$MRK · Merck & Co., Inc. SEC Filings
Position Tracker tracks 10 SEC EDGAR filings for Merck & Co., Inc. ($MRK) from October 1, 2026 through November 4, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 2 Form 8-K current event disclosures, and 6 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
$MRK 10-Q — Merck & Co., Inc.
Merck's top-line growth and Q3 profit mask a nine-month net loss driven by aggressive pipeline-building acquisitions, a key signal for investors weighing Keytruda's future.
$MRK 4 — Merck & Co., Inc.
Merck & Co. filed a Form 4 on November 3, 2026, reporting transactions by director Paul J. Diaz. According to the filing, on November 1, 2026, Diaz disposed of 200 shares of Mer…
$MRK 3 — Merck & Co., Inc.
This SEC filing is a Form 3 initial statement of beneficial ownership filed for Paul J. Diaz in connection with Merck & Co., Inc. The form indicates that, as of November 1, 2026…
$MRK 8-K — Merck & Co., Inc.
Merck's guidance raise and pipeline catalysts — including the first Phase 3 validation of a therapeutic cancer vaccine (INTerpath-001 with Moderna) — signal confidence in life b…
$MRK 3/A — Merck & Co., Inc.
This filing is an amended SEC Form 3, which is a regulatory ownership report filed by corporate insiders. It was submitted by David R. Maraldo, an executive vice president and p…
$MRK 25-NSE — Merck & Co., Inc.
Merck & Co., Inc. filed a Form 25 with the Securities and Exchange Commission on October 15, 2026, notifying the removal from listing and registration on the New York Stock Exch…
$MRK 8-K — Merck & Co., Inc.
Merck & Co., Inc. filed a current report on Form 8-K dated October 13, 2026, reporting an event dated October 9, 2026. The filing announces that the company’s Board of Directors…
$MRK 4 — Merck & Co., Inc.
Merck & Co., Inc. filed a Form 4 reporting a transaction by director Christine E. Seidman. On September 30, 2026, Seidman acquired 55.9149 phantom stock units under the company’…
$MRK 4 — Merck & Co., Inc.
This SEC Form 4 reports a change in beneficial ownership by Surendralal Lanca Karsanbhai, a director of Merck & Co., Inc. On September 30, 2026, the reporting person acquired 11…
$MRK 4 — Merck & Co., Inc.
Merck & Co., Inc. filed a Form 4 on October 1, 2026, reporting a change in beneficial ownership for Mary Ellen Coe, a member of the company’s board of directors. The filing show…